# Safety, Blood Levels and Effects of AUT00201

> **NCT04158453** · PHASE1 · COMPLETED · sponsor: **Autifony Therapeutics Limited** · enrollment: 80 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** AUT00201
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04158453
- **Lead sponsor:** Autifony Therapeutics Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-10
- **Primary completion:** 2020-12-14
- **Final completion:** 2020-12-24
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2021-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04158453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04158453, "Safety, Blood Levels and Effects of AUT00201". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04158453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*